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The presence of antigen-antibody complexes as electron-dense deposits in glomeruli 
is  well  established  in  experimental  models  and  in  human  glomerulonephritis.  The 
principal locations of these deposits are the subendothelial area, the mesangial matrix, 
and  the subepithelial  area.  The subendothelial  and mesangial  immune  deposits  are 
thought  to  arise  from  circulating  immune  complexes  (1),  whereas  several  lines  of 
evidence indicate that subepithelial  immune deposits are not deposited from circula- 
tion  but  are  locally  formed  (2).  When  immune  complexes  with  lattice  larger  than 
Ag2Abz were  injected  intravenously,  electron-dense  deposits  evolved  in  endothelial 
fenestrae,  the subendothelial  area adjacent  to the  mesangium,  and  subsequently  in 
the  mesangial  matrix  (1).  The  size  of these  deposits  varied  from  50  to  750  nm  in 
diameter, which was larger than the injected complexes that ranged up to 22 Svedberg 
U  in sedimentation  characteristics.  The development of electron-dense deposits from 
circulating immune complexes suggests that  after the initial  deposition  in glomeruli 
these complexes undergo rearrangement  to larger complexes that become identifiable 
by transmission electron microscopy. 
To  provide experimental  proof for local  rearrangement  of immune  complexes  in 
the  formation of electron-dense  deposits,  covalently cross-linked  immune complexes 
were prepared which possessed a fixed lattice and could not reequilibrate.  Aliquots of 
the same immune complexes, non-cross-linked and with comparable lattice, served as 
control preparations.  The cross-linked  and  non-cross-linked  immune complexes ini- 
tially showed comparable deposition but only the non-cross-linked complexes evolved 
into electron-dense deposits that persisted  in glomeruli. 
Materials and Methods 
Preparation of Antigens, Antibodies, and Immune Complexes.  A previously described system was 
used, consisting of multivalent 2-nitro-4-azidophenyl. human serum albumin  (NAP. HSA) ~ as 
the  antigen  and  specific antibodies  to the  haptenic  group.  The azide  group on the  hapten 
served to establish a covalent bond in the antibody-combining site (3). Briefly, monomeric NAP. 
HSA was prepared with the average of 21.6  or  19 NAP groups on each HSA molecule. For 
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some experiments the  NAP19-HSA was  trace  labeled with 1251 by the  iodine monochloride 
method as previously described (4). Antibodies to the NAP haptenic group (anti-NAP) were 
raised in rabbits by immunization  with NAP. keyhole limpet hemocyanin, isolated with affinity 
chromatography, labeled with 125I, and rendered monomeric with gel filtration (3). 
Soluble antigen-antibody  complexes with NAP. HSA and anti-NAP were made at five times 
antigen excess. These  preparations were  divided into two  aliquots. One half was  retained 
without irradiation as the non-cross-linked complexes.  The other half was irradiated for 2 h 
with light  (400-500 nm wavelength) to convert the azide group on the hapten to a  nitrene 
group that, by insertion into a carbon-hydrogen bond, established a covalent bond between the 
antigen and the antibody (3). 
The cross-linked antigen-antibody  preparation with NAP21.s.  HSA was used without further 
modification. Since this preparation showed 24.6% of free antibody on sodium dodecyl sulfate- 
polyacrylamide  gel  electrophoresis  (SDS-PAGE),  the  subsequent  preparation  was  further 
modified to decrease the amount of antibodies not covalently cross-linked with antigen. First, 
the  immune complex  preparation with  NAP19. HSA, containing 50  mg of antibodies, was 
irradiated as  described above and then gel  filtered on a  Sephacryl S-200  (Pharmacia Fine 
Chemicals, Piscataway, NJ) column in borate buffer (0.2 M borate, 0.15 M  NaC1, pH 8.0) to 
remove excess antigen. The material excluded from this column was pooled, concentrated, and 
then passed over an affinity chromatography column consisting of NAP, HSA conjugated to 
agarose. This was carried out to remove any NAP. HSA-anti-NAP complexes that would bind 
to the solid phase NAP. HSA antigen by free antibody-combining  sites or by combining sites 
that were non-cross-linked  and would equilibrate with the excess solid-phase antigen. The fall- 
through material was pooled for subsequent steps.  To further diminish potentially available 
antibody-combining  sites,  NAP-lysine (3)  was added  in molar quantity equal to the molar 
amount of total antibody present in the preparation. After overnight incubation at 4°C the 
mixture was irradiated for 2 h and unbound NAP. lysine was removed by dialysis. Then, 4 mg 
of ovalbumin (Sigma Chemical Co., St.  Louis, MO) was added per milligram of antibody to 
decrease anticipated losses of the complexes during subsequent processing, and the solution was 
concentrated by ultrafihration using a PM-10 membrane (Amicon Corp., Lexington, MA) to 
3.4 mg of antibody in immune complexes per milliliter of solution, Small losses occurred at 
each preparation step so that the final cross-linked complexes contained 60% of the starting 
antibodies. 
Characterization of the Prepared Antigen-Antibody Complexes.  The size distribution of the cross- 
linked and non-cross-linked  immune complexes was assessed on 10-30% linear sucrose density 
gradient uhracentrifugation (5). The degree of covalent cross-linking  of the preparations used 
in animal experiments was assessed by SDS-PAGE in the presence of 0.5 M urea (3). 
The disappearance of cross-linked and non-cross-linked  immune complexes from circulation 
of mice was determined by previously described methods (3). Briefy,  1.7 mg of antibody in 
immune complexes in 0.5 ml of borate buffer were injected into three C57BL/6J mice by the 
tail vein. Blood samples (20 #1) were obtained from the retro-orbital plexus at 2, 4, 6, 10, 15, 30, 
and 60 min and then 10 additional times within the 96 h period; samples from each group were 
obtained at the same time. The radioactivity precipitable with cold  10% trichloroacetic acid 
was counted. The 0 time value was extrapolated from the first  three values and the fraction 
remaining in circulation and the means and standard deviations were calculated for each time 
point, plotted, and analyzed by graphic peeling (6). 
Renal Localization of Immune Complexes.  Female C57BL/6J mice, weighing ~20 g were used. 
Immune complexes of each preparation were injected in 0.5 ml volume containing 1.7 mg of 
antibody in immune complexes for each dose. The injections were given at time 0, 20, and 40 
min, using one or two mice for each time point. Three injections were given for two reasons. 
First, high concentrations of antibodies were  avoided to  minimize losses. Second, multiple 
injections would prolong the exposure of kidneys to immune complexes, since as a function of 
the  NAP  groups  on  HSA,  the  half-lives of the  antigen alone and  of immune complexes 
containing the antigen were shortened  (3,  4),  Mice were sacrificed at  the stated times and 
kidneys were  removed  and  processed  for  immunofluorescence and  electron  microscopy as 
previously described (1). The following specific, fluoresceinated antibodies were used to examine 
the renal tissues:  goat  antibodies to rabbit IgG (Kallestad Laboratories Inc., Chaska, MN), 1518  REARRANGEMENT OF GLOMERULAR IMMUNE  COMPLEXES 
goat antibodies to HSA (anti-HSA) (Kallestad Laboratories, Inc.) to stain for the presence of 
the carrier molecule in  NAP.HSA, and  goat antibodies to mouse C3  (Cappel Laboratories, 
Cochranville, PA). The intensity of fluorescence in glomeruli was graded 0-4+, in peritubular 
capillaries 0-2+, and +  to indicate a trace of fluorescence. A minimum of eight glomeruli was 
examined by electron microscopy in each specimen. The presence of electron-dense deposits 
was graded as ++  (extensive), +  (few), _+ (occasional), and 0 (none). 
Results 
Characteristics of the Immune Complex.  Because the initial preparation of photoacti- 
vated immune complexes with NAP21.6. HSA contained 25.2% of antibodies that were 
not  covalently cross-linked,  additional  steps  were  taken  to  decrease  the  antibody- 
combining  sites  potentially  available  for  rearrangement  of  the  lattice.  With  the 
photoactivated NAP19. HSA-anti-NAP complexes, gel filtration and affinity chroma- 
tography with agarose-antigen columns were used sequentially for this purpose. As a 
final step, free hapten was added and photoactivation was carried out  to covalently 
cross-link the hapten  to any antibody-combining sites accessible to the hapten.  The 
cross-linked and  non-cross-linked final preparations of immune  complexes used  for 
the glomerular localization studies had comparable lattices as determined by sucrose 
density gradient ultracentrifugation (Fig. 1). Both small-latticed (AglAbl and AgzAb2) 
and large-latticed (greater than  Ag2Ab2) complexes were present, comparable to the 
immune  complexes  made  with  HSA and  anti-HSA in  earlier studies  (7).  By  SDS- 
PAGE analysis the nonirradiated complexes were dissociated into free antibody and 
antigen, whereas in the final preparation of the cross-linked immune complexes with 
NAP19. HSA, only 9.5% of antibodies were not covalently cross-linked (Fig. 2). 
Since  the  NAP  groups  present  on  HSA  enhanced  the  clearance  of  immune 
complexes containing NAP,HSA  (3),  the clearance of the immune  complexes used 
for glomerular localization was examined. When single doses of 131I-NAP19. HSA and 
lzSI-anti-NAP complexes, prepared identically to the non-cross-linked complexes used 
for glomerular localization, were injected into mice, the antigen  and antibody were 
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Fro.  1.  Sucross  density gradient ultracentrifugation  patterns of non-cross-linked and cross-linked 
NAP19-HSA-125I-anti-NAP  complexes used for experiments in mice. 10-30% sucrose was used for 
linear gradients; the top of the gradient is represented by 100% of gradient volume. The non-cross- 
linked  (---)  and  the  cross-linked (--)  complexes had  comparable lattice as shown by the 
distribution of radiolabeled antibodies in the complexes. The position of sedimentation of antibody 
alone is marked with an arrow. MANNIK,  AGODOA,  AND  DAVID  1519 
×  t 
E 
°  41  _  '' 
f'-  \ 
[  f  I  '  I  ~  l  '  I 
20  40  60  80  100 
Percent gel length 
FIo.  2.  SDS-PAGE patterns of non-cross-linked and cross-linked NAP19.HSA-125I-anti-NAP com- 
plexes used for experiments in mice. The non-cross-linked complexes (---)  were dissociated into 
free radiolabeled antibody and unlabeled antigen. From the cross-linked complexes (  ), 9.5% of 
the  radiolabeled  antibody  was  dissociated  and  migrated  in  the  same  area  as  the  antibodies 
dissociated from non-cross-linked complexes. 
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FIG.  3.  Curves for the removal of non-cross-linked z31I-NAPzg. HSA-125I-anti-NAP and cross-linked 
NAP19-HSA-12Sl-anti-NAP complexes from the circulation of mice. The mean --. 1 SD is plotted for 
131  1~5  each experimental point. The  I-NAP19-HSA (0) and the  I-anti-NAP (O)  in non-cross-linked 
complexes were initially removed together as seen in the insert for the 60 rain time period;  after 4 
h  the antigen removal continued at a  fast rate, leaving the dissociated antibody in circulation. The 
l~SI-anti-NAP  (A)  in cross-linked complexes was initially removed comparably to the non-cross- 
linked complexes, and <2% of the antibody in the cross-linked complexes showed a slow clearance. 
initially  removed in  comparable manner.  After 4  h,  however,  the  antigen  removal 
was more rapid than antibody removal (Fig. 3). After ~20 h essentially only the 125I- 
antibody remained in circulation,  and it was degraded with a  half-life of 94 h. The 
intercept of this exponential component (5.7%)  suggests that ~ 10% of the antibodies 
were dissociated  from the immune complexes, considering the previously examined 
clearance  of anti-NAP  alone  (3).  These  observations  indicated  that  the  immune 
complexes were dissociated in circulation due to the previously known rapid clearance 
of NAP.HSA  with  more  than  seven  NAP  groups  (4).  In  contrast,  with  purified, 
covalently cross-linked  NAP19.HSAJ25I-anti-NAP  complexes,  the  clearance  of the 
az5I-anti-NAP was  initially  comparable  to  the  clearance  of antibody  in  non-cross- 1520  REARRANGEMENT  OF GLOMERULAR IMMUNE  COMPLEXES 
linked complexes (Fig. 3). <2% of the radioactivity had a slow exponential component 
that  paralleled the clearance of the antibody dissociated from  complexes that  were 
non-cross-linked. As previously shown, in cross-linked immune complexes the removal 
of antigen  and  antibody  was  parallel  (3)  and  therefore  in  the  present  study  dual 
labeling of the cross-linked complexes was not used.  Most important  for the present 
study,  the  initial  clearance  of the  cross-linked  complexes  was  not  faster  than  the 
clearance of non-cross-linked complexes (insert, Fig. 3). 
Glomerular and Extraglomerular  Renal Localization  of Immune Complexes.  For the initial 
experiment,  NAP21.6.HSA-anti-NAP  complexes  were  prepared  at  fivefold  antigen 
excess  and  one  half of the  complexes were  irradiated  for  cross-linking.  No  further 
purification steps were  carried out.  In  SDS-PAGE analysis, 25.2%  of the  anti-NAP 
dissociated  from  the  cross-linked  complexes,  comparable  to  previous  findings  on 
photoactivation of similar complexes  (3).  When  these complexes were  injected into 
mice and the left kidney removed at 4,  17, or 73 h  by previously described procedures 
(8), the incompletely cross-linked complexes caused glomerular deposits that were less 
extensive  than  the  deposits  resulting  from  complexes  that  were  non-cross-linked 
(Table I), as determined by immunofluorescence microscopy. Thus, these experiments 
suggested that when the majority of complexes were cross-linked, glomerular deposi- 
tion was diminished from 4+ to 2+ both 4 and  17 h  after injection. To prove that the 
deposits with  both  preparations were  immunospecific,  50  mg of free  NAPm.6-HSA 
TABLE  I 
Glomerular Deposition of Non-cross-linked or Cross-linked NAP21.6.  HSA- 
Anti-NAP Complexes that Were  Not Further Purified, 
Detected by Immunofluorescence  Microscopy* 
Non-cross-linked corn-  Time  plexes  Cross-linked complexes 
h 
4  4+  2+ 
17  4+  2+ 
73  2+  +-- 
* Sections were stained with antibodies to rabbit IgG. By SDS-PAGE, 25.2% 
of the radiolabeled anti-NAP dissociated from complexes. 
TABLE II 
Glomerular and Peritubular Deposition of Non-cross-linked or Cross-linked, 
Further Purified NAP19. HSA-Anti-NAP Complexes, 
Detected by Immunofluorescence  Microscopy* 
Time 
Non-cross-linked complexes  Cross-linked complexes 
Glomerular  Peritubular  Glomerular  Peritubular 
h 
1  2+  ++  2+  ++ 
4  3.5+  ++  1.5+  ++ 
8  4+  +  +__  + 
24  4+  0  +  0 
96  3.5+  0  ---  0 
* Sections were stained with antibodies  to rabbit IgG. By SDS-PAGE, 9.5% of the 
radiolabeled anti-NAP dissociated from complexes. MANNIK,  AGODOA,  AND  DAVID 
TABLE  III 
Detection  of Glomerular Electron-dense Deposits after Administration  of Non-cross- 
linked or Cross-linked NAP19. HSA-Anti-NAP Complexes * 
1521 
Time 
Non-cross-linked complexes  Cross-linked complexes 
Subendothelial  Mesangial  Subendothelial  Mesangial 
h 
1  +  +  0  0 
4  ++  ++  0  0 
24  +  ++  0  0 
* Presence of  electron-dense deposits graded as ++ (extensive), +  (few), -- (occasional), 
and 0  (none). 
Fro.  4.  Glomerular immunofluorescence patterns after staining with fluoresceinated antibodies to 
rabbit  IgG in mice injected with non-cross-linked or cross-linked NAP19. HSA-12SI-anti-NA'P com- 
plexes.  At  L h  the glomeruli of mice receiving non-cross-linked complexes (A)  and  cross-linked 
complexes (B)  stained 2+. At 24 h  the glomeruli of mice receiving non-cross-linked complexes (C) 
stained 4+  but  the glomeruli of mice receiving cross-linked complexes (D)  stained  +  (trace).  At 
96 h  the glomeruli of mice receiving non-cross-linked complexes (E)  stained 3.5+  and were  +  or 
negative in mice given cross-linked complexes (F). 1522  REARRANGEMENT  OF GLOMERULAR IMMUNE COMPLEXES 
was administered intraperitoneally after the completion of surgery for removal of the 
left kidney. The right kidney was removed 16 h later to determine if the excess antigen 
had solubilized  the glomerular deposits as previously described  (9).  In all mice, the 
second  kidney  contained  no  deposits  of rabbit  IgG or  antigen,  as  determined  by 
immunofluorescence microscopy, indicating that the excess antigen had released the 
deposited complexes. 
In the purified preparation of cross-linked NAP19.HSA-anti-NAP  complexes, still 
9.5% of the anti-NAP dissociated by SDS-PAGE analysis. The comparison of glomer- 
ular  deposition  of  this  preparation  and  the  non-cross-linked  control  preparation 
revealed interesting differences (Table II). The non-cross-linked preparation showed 
2+ glomerular deposits at  1 h, increased to 4+ deposits by 8 h, and declined by 96 h. 
The cross-linked complexes at 1 h also showed 2+ deposits, but these did not increase 
further,  and  from 8  to 96 h  showed only trace (+)  deposits  (Table III, Fig.  4). The 
staining for HSA in the NAP19- HSA paralleled the staining for rabbit IgG (data not 
shown).  The glomeruli of mice given non-cross-linked complexes stained  for mouse 
C3 as follows:  l+ at 8 h, 2.5+ at 24 h,  1+ at 96 h, and negative at earlier times. The 
glomeruli of mice given cross-linked complexes were negative for mouse C3 at all time 
points. 
The  injection  of  a  single  dose  of  the  non-cross-linked  NAP19.HSA-anti-NAP 
complexes also caused glomerular deposits that were  1.5+ at  1 h,  1+ at 8 h, and  1+ 
at 96 h, when stained for rabbit IgG. To rule out the glomerular deposition of NAP19- 
HSA alone, mice were injected repeatedly with  1.41 mg of the antigen alone, and by 
immunofluorescence  microscopy  glomerular  binding  of the  antigen  could  not  be 
found. 
The  sequence  of observed events  suggested  that  the  non-cross-linked  and  cross- 
linked immune complexes initially became associated with glomerular structures in a 
comparable manner, as determined by immunofluorescence. The deposited non-cross- 
linked complexes persisted, but the cross-linked complexes failed to persist in glomer- 
uli. 
With non-cross-linked and cross-linked complexes, extensive fluorescence was seen 
adjacent  to the peritubular capillaries in the renal cortex and medulla at  1 and 4 h 
after injection  of the complexes, but  by 8  h  these  deposits had  diminished  and by 
24  h  were  totally  absent  (Fig.  5),  as  noted  in  an  earlier  publication  (1).  It  was of 
interest  that  the fate of these deposits paralleled the fate of glomerular fluorescence 
after injection of cross-linked complexes (Table II). 
Transmission electron  microscopic studies  were carried  out  on  kidney specimens 
from mice at  1, 4, and 24 h  after administration of non-cross-linked or cross-linked 
complexes. After administration  of non-cross-linked complexes, only a  few electron- 
dense  deposits  were  seen  at  1  h  in  subendothelial  and  mesangial  areas.  By  4  h 
subendothelial  deposits had increased and extensive mesangial deposits were present 
(Fig. 6).  By 24 h  the subendothelial  deposits had decreased and extensive mesangial 
deposits  persisted  (Table  Ill).  In  contrast,  after the  administration  of cross-linked 
complexes no electron-dense deposits could be identified in the 1, 4, or 24 h specimens 
(Fig. 6), even though immunofluorescence indicated that rabbit IgG and the NAP19. 
HSA molecules were present. These findings suggested that the cross-linked immune 
complexes had  not  rearranged  or condensed  into  material  visible as electron-dense 
deposits. MANNIK, AGODOA, AND DAVID  1523 
FIG. 5.  Peritubular  immunofluorescence patterns after staining with fluoresceinated antibodies to 
rabbit IgG in mice injected with non-cross-linked or cross-linked NAPxg-  HSA-anti-NAP complexes, 
At 4 h the staining was ++ in mice that received non-cross-linked (A) or cross-linked (B) complexes. 
At 24 h no peritubular staining was found in capillaries after administration of non-cross-linked (C) 
or cross-linked (D) complexes. The positive staining in the right upper corner of (C) is glomerular 
staining that persists in mice given the non-cross-linked complexes. 
The glomeruli of mice given non-cross-linked complexes had increased cellularity, 
as well as two to three polymorphonuclear leukocytes per glomerulus. The glomeruli 
of mice given cross-linked complexes also had increased cellularity but no increase in 
polymorphonuclear leukocytes. 
The peritubular  capillaries were carefully examined for electron-dense materials in 
the same specimens.  Comparable  electron-dense  deposits were  found at  4  h  (Table 
III), both in the mice that received the non-cross-linked  and cross-linked complexes 
(Fig.  7).  These deposits were found outside of the tubular  basement  membrane and 
outside of the capillary lumen. 
Discussion 
The present  data indicate that circulating immune complexes, after initial  attach- 
ment  to  glomerular  structures,  must  undergo  further  rearrangement  to  persist  in 
subendothelial  and  mesangial  areas  and  to  become  detectable  as  electron-dense 
deposits.  This conclusion was supported  by the observation that the cross-linked and 
non-cross-linked immune complexes had comparable degrees of deposition at  1 h, as 
detected  by  immunofluorescence  microscopy for the  antibodies  and  antigen  in  the 
injected  complexes.  At this  time  point,  sparse  electron-dense  deposits  could be seen 
after  injection  of the non-cross-linked complexes, but  were absent  after  injection of 
the cross-linked complexes. With passage of time the mice that received the non-cross- 
linked  preparations  showed  increasing  glomerular  deposits  by immunofluorescence 
microscopy and  increasing  electron-dense  deposits,  whereas  in  mice given the cross- 
linked  complexes  the  deposits  declined  and  electron-dense  deposits  did  not  evolve. 1524  REARRANGEMENT  OF  GLOMERULAR  IMMUNE  COMPLEXES 
Ft~.  6.  Electron micrographs of glomeruli of mice injected with non-cross-linked or cross-linked 
NAP19,HSA-anti-NAP  complexes. At  1 h  in  mice  given  non-cross-linked complexes  (A)  sparse 
electron-dense deposits (arrows) were present in association with endothelial cells and in mesangial 
matrix. At 4 h in mice given non-cross-linked complexes (B) subendothelial and extensive mesangial 
deposits were present. Mice given cross-linked complexes did not develop electron-dense deposits in 
glomeruli, as panel  (C)  shows for the 4  h  time point.  Mes, mesangial cells; Epi, epithelial cells; 
Endo, endothelial cells; MM, mesangial matrix. (A) ×  35,000;  (B) ×  12,000;  (C)  ×  12,000. MANNIK, AGODOA, AND DAVID  1525 
Fro.  7.  Electronmicrographofaperitubularareaofamouseinjectedwithnon-cross-linkedNAP19. 
HSA-anti-NAP complexes  4 h earlier. Electron-dense deposits (arrows) were present outside of the 
capillary  lumen and  adjacent to  the  tubular  basement membrane. TBM,  tubular  basement 
membrane; RBC, erythrocyte; CL, capillary lumen. X 10,000. 
The  trace  amounts  of deposits  seen  by  immunofluorescence  microscopy  after  the 
injection of cross-linked complexes were attributed  to the residual antibodies  (9.5%) 
that were not covalently cross-linked, since the reduction of free antibody from 25.2 
to 9.5% by SDS-PAGE analysis reduced the persisting deposits from 2+ to trace (+_), 
as  shown  in  Tables  I  and  II.  The  inability  of cross-linked  immune  complexes  to 
rearrange in vitro was previously shown by the lack of precipitation and the absence 
of changes  in  lattice  by gradient  ultracentrifugation  after the  complexes had  been 
purified and concentrated  (3). 
The  mechanism  for  the  initial  attachment  of cross-linked  and  non-cross-linked 
immune  complexes  to  glomerular  structures  is  not  fully  known.  The  electrostatic 
interaction  between  positively  charged  (cationic)  antibodies  and  fixed  negative 
charges in the glomerular basement membrane constitute one factor that promoted 
the initial interaction and subsequent development and persistence of electron-dense 
deposits in the subendothelial  areas of the glomerular capillaries  (10).  Other factors 
very likely contribute to this initial interaction as well. 
The further rearrangement of immune complexes in subendothelial and mesangial 
areas appears as a  requirement  for their persistence and condensation  into electron- 
dense deposits. Antigen-antibody bonds that can rearrange are needed for this event 
since the cross-linked complexes did not persist or develop into electron-dense deposits. 
Furthermore,  the  development of the  persisting deposits was immunospecific, since 
the  deposits  formed with  partially  cross-linked or non-cross-linked  complexes were 
dispersed with administration of excess antigen as described in earlier studies  (9).  In 
addition,  as noted by Kube~ (11), when  mice were simultaneously immunized with 
ferritin and fibrinogen, each deposit contained only one antigen. The work of Michael 
et al. (reviewed in reference 12) showed that aggregated human IgG caused extensive 1526  REARRANGEMENT OF GLOMERULAR IMMUNE COMPLEXES 
mesangial deposits  in rats, suggesting that  nonimmunospecific interactions  can also 
lead  to  development  of large  mesangial  deposits.  It  is  noteworthy  that  extensive 
nonimmunospecific  interactions  were  observed  with  aggregated  human  IgG  (13). 
Interestingly, local rearrangement of large immune complexes was demonstrated  as 
a  requirement for phagocytosis by monocytes, using covalently cross-linked immune 
complexes (14). In the interaction with monocytes, binding of immune complexes to 
the Fc receptors constituted  the process that caused increased local concentration of 
immune complexes that  led to rearrangement  to larger lattices and finally to inter- 
iorization. In glomeruli, locally increased concentration of immune complexes presum- 
ably occurred by electrostatic interactions for subendothelial deposit formation, as in 
a  previously described model system (10).  The potential role of glomerular filtration 
for the local increase of immune complexes for rearrangement has not been established. 
The  observed  deposition  of the  non-cross-linked  immune  complexes  was  more 
extensive and the deposits persisted longer than in previously described results with 
complexes formed with HSA and antibodies to HSA at five times antigen excess (1). 
The  increased  deposition  of complexes in  the  present  data  was  in  part  due  to  the 
rapid  removal  of  the  excess  NAP.HSA  as  previously  described  (4),  leading  to 
dissociation  of circulating  immune complexes and  residual  free antibody.  The free 
antibody  then  could  have  combined  with  the  free  antigenic  determinants  in  the 
complexes  already  deposited  in  glomeruli,  as  suggested  for  the  chronic  immune 
complex disease model induced with bovine serum albumin (15). The presence of fi'ee 
antibody,  however,  was  unlikely  to  account  for  the  proposed  rearrangement  and 
formation of electron-dense deposits since similar deposits occurred with the previously 
described  HSA-anti-HSA complexes, made at  five times  antigen  excess, where  the 
free antigen  persisted  (1).  Similarly, when  complexes with  cationized  antibodies  at 
five times antigen excess were administered, extensive deposits formed in spite of rapid 
removal  of cationized  antibodies,  leaving  free  excess  antigen  in  circulation  (10). 
Therefore, we concluded that the free antibody contributed to the extensive deposits 
but  was not  solely responsible for the development and persistence of the electron- 
dense deposits in glomeruli. 
It  was  of considerable  interest  that  both  the  cross-linked  and  non-cross-linked 
immune complexes caused comparable deposits adjacent to peritubular capillaries by 
immunofluorescence. These deposits were transient  and lasted a  time period compa- 
rable to the glomerular deposits with cross-linked complexes (Table II). By electron 
microscopy these deposits were recognized at 4, but not at  1 h, both in the mice that 
received  the  cross-linked  and  non-cross-linked  immune complexes.  These  electron- 
dense deposits were outside of the peritubular capillaries and outside but adjacent to 
the tubular basement membrane. The mechanisms of the formation of these deposits 
and  the  reasons  for the  transient  existence  of these  deposits  are not  known  at  this 
time. 
The observations that electron-dense glomerular deposits evolved after rearrange- 
ment  of  initially  deposited  immune  complexes  and  that  only  the  large  deposits 
persisted indicate that the involved antigen-antibody system must have the potential 
to  form  precipitates.  This  conclusion  suggests  that  the  antigen-antibody  systems 
involved in the formation of subendothelial and mesangial electron-dense deposits in 
human glomerulonephritides must also be caused by precipitating antigen-antibody 
systems among the circulating immune complexes. This concept should facilitate the MANNIK, AGODOA, AND DAVID  1527 
search  and  identification  of circulating immune complexes that  participate  in  the 
genesis of glomerulonephritides with subendothelial  and mesangial deposits. In ad- 
dition, the presented data indicate that some immune deposits detectable by immu- 
no  fluorescence microscopy may not be identifiable as electron-dense deposits. 
Summary 
Covalently,  cross-linked  immune  complexes  were  prepared  with  multivalent  2- 
nitro-4-azidophenyl.human serum albumin  (NAP.HSA) and antibodies to NAP at 
five times antigen excess.  After purification with gel filtration, affinity chromatogra- 
phy with antigen-agarose column, and addition of the hapten, 9.5% of the antibodies 
dissociated from the complexes by sodium dodecyl sulfate-polyacrylamide gel electro- 
phoresis analysis. After injection of these cross-linked immune complexes into mice, 
glomeruli stained  for the  complexes by immunofluorescence microscopy for only a 
few hours and electron-dense deposits were not detected. In contrast, when the same 
immune complexes with comparable lattice but without covalent cross-linking were 
administered to a second group of mice, the initial deposition by immunofluorescence 
was comparable and then increased to extensive deposits that persisted to 96 h. In this 
second group of mice extensive electron-dense deposits evolved. These observations 
supported the conclusion that the immune complexes initially deposited from circu- 
lation must undergo rearrangement to persist and to form electron-dense deposits in 
glomeruli. The covalently cross-linked immune complexes existed in glomeruli only 
for a short period of time since these complexes could not rearrange. 
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